Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Impact of Mogamulizumab-Containing Chemotherapy on HBV Reactivation in Patients with T-Cell Lymphoma: A Multicenter Retrospective Observational Study (PROACTIVE-MOGA)

Blood (2023) 142 (Supplement 1): 6192.

https://doi.org/10.1182/blood-2023-185878

Published: 2023

Journal Articles

Final Analysis of the Randomized Phase II/III Study of Standard R-CHOP Versus CHOP Combined with Dose-Dense Weekly Rituximab for DLBCL: JCOG0601

Blood (2023) 142 (Supplement 1): 1724.

https://doi.org/10.1182/blood-2023-178551

Published: 2023

Journal Articles

A Phase 1 Trial of OPB-111077 in Combination with Bendamustine (B) and Rituximab (R) in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Preliminary Results of Dose-Escalation Stage

Tomomi Toubai, Junya Kuroda, Youko Suehiro, Yuko Mishima, Kazutaka Sunami, Koji Kato, Nobuhiko Uoshima, Takahiro Kumode, Ai Ota, Kaori Mitsuki, Daisuke Yokota, Yuri Sano, Yasuhito Terui

Blood (2023) 142 (Supplement 1): 4464.

https://doi.org/10.1182/blood-2023-179716

Published: 2023

Journal Articles

Donor NK Cell Education By KIR3DL1 and HLA-B Associates with Reduced Relapse in Unrelated Bone Marrow Transplantation for Adult T-Cell Leukemia

Blood (2023) 142 (Supplement 1): 4982.

https://doi.org/10.1182/blood-2023-185474

Published: 2023

Journal Articles

Cytomegalovirus-Seronegative Plus Leukoreduced Blood Products Are Still Superior to Only Leukoreduced Products in Preventing Transfusion-Transmitted Cytomegalovirus Infection

Kimikazu Yakushijin, Ryu Yanagisawa, Sachiko Seo, Masao Ogata, Michiko Kajiwara, Naoyuki Uchida, Youko Suehiro, Noriko Doki, Daiichiro Hasegawa, Satoshi Yoshihara, Kensuke Usuki, Katsuyoshi Koh, Yoshinobu Kanda, Mineo Kurokawa, Makoto Onizuka, Fumihiko Ishimaru, Yoshiko Atsuta, Takahiro Fukuda, Hideki Nakasone

Blood (2023) 142 (Supplement 1): 2666.

https://doi.org/10.1182/blood-2023-178182

Published: 2023

Journal Articles

Final Analysis of JCOG0203 for Advanced-Stage Indolent B-Cell Lymphoma 15 Years after the End of Enrollment: Pooled Analysis of Arms a and B for Follicular Lymphoma

Takashi Watanabe, Kensei Tobinai, Ｍasashi Wakabayashi, Dai Maruyama, Kazuhito Yamamoto, Nobuko Kubota, Kazuyuki Shimada, Kohsuke Asagoe, Motoko Yamaguchi, Kiyoshi Ando, Michinori Ogura, Junya Kuroda, Youko Suehiro, Yoshihiro Matsuno, Kunihiro Tsukasaki, Hirokazu Nagai

Blood (2022) 140 (Supplement 1): 3615–3617.

https://doi.org/10.1182/blood-2022-159967

Published: 2022

Journal Articles

Outcomes of Transplant-Eligible Patients with Myelodysplastic Syndrome-Refractory Anemia with Excess Blasts Registered in a Prospective Observational Study: The JALSG-CS11-MDS-SCT

Blood (2021) 138 (Supplement 1): 2925.

https://doi.org/10.1182/blood-2021-147587

Published: 2021

Journal Articles

Asian Multinational Phase II Study of Darinaparsin in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

Noriko Fukuhara, Won Seog Kim, Dok Hyun Yoon, Eiju Negoro, Kazuhito Yamamoto, Toshiki Uchida, Koji Izutsu, Yasuhito Terui, Hideaki Nakajima, Kiyoshi Ando, Youko Suehiro, Hye Jin Kang, Po-Shen Ko, Fumiko Nagahama, Yusuke Sonehara, Hirokazu Nagai, Hwei-Fang Tien, Yok-Lam Kwong, Kensei Tobinai

Blood (2021) 138 (Supplement 1): 1376.

https://doi.org/10.1182/blood-2021-145512

Published: 2021

Journal Articles

Dasatinib-Based Two-Step Induction Prior to Allogeneic Hematopoietic Cell Transplantation for Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the JALSG Ph+ALL213 Study

Blood (2019) 134 (Supplement_1): 743.

https://doi.org/10.1182/blood-2019-123382

Published: 2019

Journal Articles

Randomized Phase II/III Study of Standard R-CHOP Versus CHOP Combined with Dose-Dense Weekly Rituximab (RW-CHOP) for Previously Untreated DLBCL: JCOG0601

Blood (2018) 132 (Supplement 1): 4194.

https://doi.org/10.1182/blood-2018-99-110201

Published: 2018

Journal Articles

Tax-Targeting Dendritic Cell Therapy for ATL: A Phase Ia/Ib Clinical Study

Motoaki Shiratsuchi, MDPhD, Tetsuya Fukuda, MD PhD, Tadafumi Iino, MD PhD, Atsuhiko Hasegawa, PhD, Jun-ichirou Yasunaga, MD PhD, Ken Watanabe, MD PhD, Akie Hirata, MD PhD, Hayato Utsunomiya, MD, Hirofumi Ohno, MD, Takashi Ishida, MD PhD, Koichi Akashi, MD PhD, Masao Matsuoka, MDPhD, Mari Kannagi, MD PhD, Youko Suehiro, MDPhD

Blood (2018) 132 (Supplement 1): 1649.

https://doi.org/10.1182/blood-2018-99-113315

Published: 2018

Journal Articles

Updated Report of a Phase I/II Multicenter Study of Forodesine, a Purine Nucleoside Phosphorylase Inhibitor, in Japanese Patients with Relapsed Peripheral T-Cell Lymphoma

Blood (2017) 130 (Supplement 1): 4075.

https://doi.org/10.1182/blood.V130.Suppl_1.4075.4075

Published: 2017

Journal Articles

Randomized Phase II Study of R-CHOP-14 Versus R-CHOP-14 Followed By Chaser As Induction Therapy for High-Dose Chemotherapy (HDT), LEED, and Autologous Stem-Cell Transplantation (ASCT) in Poor-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Japan Clinical Oncology Group (JCOG) Study (JCOG0908)

Blood (2017) 130 (Supplement 1): 4127.

https://doi.org/10.1182/blood.V130.Suppl_1.4127.4127

Published: 2017

Journal Articles

Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome in Lymphoma Patients Receiving Hematopoietic Cell Transplantation

Satoshi Yamasaki, MD PhD, Ritsuro Suzuki, MD, Kaoru Hatano, Kentaro Fukushima, MD PhD, Hiroatsu Iida, MD PhD, Satoko Morishima, MD, Youko Suehiro, MD, Takahiro Fukuda, MD, Naoyuki Uchida, MD PhD, Takashi Uchiyama, MD, Yoshiko Atsuta, MD PhD, Junji Suzumiya, MD PhD

Blood (2016) 128 (22): 827.

https://doi.org/10.1182/blood.V128.22.827.827

Published: 2016

Journal Articles

Allogeneic Peripheral Blood Stem Cell Transplantation Using Reduced-Intensity Conditioning Regimen with Fludarabine and Busulfan from HLA-Matched Related Donor for Elderly Adult T-Cell Leukemia/Lymphoma: Results of Multicenter Phase II Study (ATL-NST-3)

Ryuji Tanosaki, MD PhD, Ilseung Choi, MD, Mototsugu Shimokawa, PhD, Atae Utsunomiya, MD PhD, Masahito Tokunaga, MD, Nobuaki Nakano, MD, Takahiro Fukuda, MD, Hirohisa Nakamae, Shigeki Takemoto, MD PhD, Shigeru Kusumoto, MD PhD, Takeaki Tomoyose, Eisaburo Sueoka, MD PhD, Motoaki Shiratsuchi, Youko Suehiro, MD, Takeharu Yamanaka, PhD, Jun Okamura, MD, Naokuni Uike

Blood (2014) 124 (21): 2580.

https://doi.org/10.1182/blood.V124.21.2580.2580

Published: 2014

Journal Articles

A Therapeutic Vaccine In Adult T-Cell Leukemia Patients With Autologous Dendritic Cells Pulsed With Peptides Corresponding To Tax-Specific Cytotoxic T Lymphocyte Epitopes

Tadafumi Iino, MD, Youko Suehiro, MD, PhD, Atsuhiko Hasegawa, PhD, Nobukazu Watanabe, MD, PhD, Ryuji Tanosaki, MD, PhD, Atae Utsunomiya, M.D., PhD, Masao Matsuoka, MD, PhD, Takanori Teshima, MD, PhD, Koichi Akashi, MD, PhD, Naokuni Uike, MD, PhD, Jun Okamura, MD, PhD, Mari Kannagi, MD, PhD

Blood (2013) 122 (21): 5130.

https://doi.org/10.1182/blood.V122.21.5130.5130

Published: 2013

Journal Articles

Expression Cloning of Genes Enabling Erythropoietin -Independent Erythropoiesis in Vitro.

Tomoko Yokoo, Ryo Kurita, Atsushi Takahashi, Michiyo Okada, Hirotaka Kawano, Yoshie Miura, Takafumi Hiramoto, Hiroyuki Inoue, Youko Suehiro, Daisuke Sugiyama, Hua Lu, Akihiko Yoshimura, Norio Komatsu, Kenzaburo Tani

Blood (2009) 114 (22): 3608.

https://doi.org/10.1182/blood.V114.22.3608.3608

Published: 2009

Journal Articles

Efficient Induction of Hematopoietic Progenitor/Stem Cell Differentiation by Lentiviral Gene Transduction of TAL1/SCL Into Human ES Cells.

Ryo Kurita, PhD, Yoshie Miura, PhD, Michiyo Okada, Rui Kageyama, Takafumi Hiramoto, Tomoko Yokoo, Megumi Narusawa, Youko Suehiro, PhD, M.D., Hiroyuki Inoue, PhD, M.D., Tomotoshi Marumoto, PhD, M.D., Atsushi Takahashi, PhD, M.D., Kenzaburo Tani, PhD, M.D.

Blood (2009) 114 (22): 1477.

https://doi.org/10.1182/blood.V114.22.1477.1477

Published: 2009

Journal Articles

Production of Megakaryocytes and Platelets from Common Marmoset (Callithrix jacchus) ES Cells by Constitutive Expression of tal1/scl Gene.

Ryo Kurita, PhD, Tomoko Yokoo, Erika Sasaki, Ph.D., Yan Dong, Youko Suehiro, M.D., Ph.D., Yoshikuni Tanioka, Ph.D., Yasushi Soda, M.D., Ph.D., Norio Komatsu, M.D., Ph.D., Kenzaburo Tani, M.D., Ph.D.

Blood (2006) 108 (11): 956.

https://doi.org/10.1182/blood.V108.11.956.956

Published: 2006

Journal Articles

Secretable Human Megakaryocyte Factor V Endocytosed from Plasma in Complex with Multimerin: The Origin of Human Megakaryocyte Factor V.

Youko Suehiro, MD, PhD, Dragoslava K. Veljkovic, Nola Fuller, Yasuaki Motomura, MD, PhD, Jean Masse, Elizabeth Cramer, MD, PhD, Catherine P.M. Hayward, MD, PhD

Blood (2004) 104 (11): 1932.

https://doi.org/10.1182/blood.V104.11.1932.1932

Published: 2004

NARROW

Impact of Mogamulizumab-Containing Chemotherapy on HBV Reactivation in Patients with T-Cell Lymphoma: A Multicenter Retrospective Observational Study (PROACTIVE-MOGA)

Final Analysis of the Randomized Phase II/III Study of Standard R-CHOP Versus CHOP Combined with Dose-Dense Weekly Rituximab for DLBCL: JCOG0601

A Phase 1 Trial of OPB-111077 in Combination with Bendamustine (B) and Rituximab (R) in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Preliminary Results of Dose-Escalation Stage

Donor NK Cell Education By KIR3DL1 and HLA-B Associates with Reduced Relapse in Unrelated Bone Marrow Transplantation for Adult T-Cell Leukemia

Cytomegalovirus-Seronegative Plus Leukoreduced Blood Products Are Still Superior to Only Leukoreduced Products in Preventing Transfusion-Transmitted Cytomegalovirus Infection

Final Analysis of JCOG0203 for Advanced-Stage Indolent B-Cell Lymphoma 15 Years after the End of Enrollment: Pooled Analysis of Arms a and B for Follicular Lymphoma

Outcomes of Transplant-Eligible Patients with Myelodysplastic Syndrome-Refractory Anemia with Excess Blasts Registered in a Prospective Observational Study: The JALSG-CS11-MDS-SCT

Asian Multinational Phase II Study of Darinaparsin in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

Dasatinib-Based Two-Step Induction Prior to Allogeneic Hematopoietic Cell Transplantation for Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the JALSG Ph+ALL213 Study

Randomized Phase II/III Study of Standard R-CHOP Versus CHOP Combined with Dose-Dense Weekly Rituximab (RW-CHOP) for Previously Untreated DLBCL: JCOG0601

Tax-Targeting Dendritic Cell Therapy for ATL: A Phase Ia/Ib Clinical Study

Updated Report of a Phase I/II Multicenter Study of Forodesine, a Purine Nucleoside Phosphorylase Inhibitor, in Japanese Patients with Relapsed Peripheral T-Cell Lymphoma

Randomized Phase II Study of R-CHOP-14 Versus R-CHOP-14 Followed By Chaser As Induction Therapy for High-Dose Chemotherapy (HDT), LEED, and Autologous Stem-Cell Transplantation (ASCT) in Poor-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Japan Clinical Oncology Group (JCOG) Study (JCOG0908)

Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome in Lymphoma Patients Receiving Hematopoietic Cell Transplantation

Allogeneic Peripheral Blood Stem Cell Transplantation Using Reduced-Intensity Conditioning Regimen with Fludarabine and Busulfan from HLA-Matched Related Donor for Elderly Adult T-Cell Leukemia/Lymphoma: Results of Multicenter Phase II Study (ATL-NST-3)

A Therapeutic Vaccine In Adult T-Cell Leukemia Patients With Autologous Dendritic Cells Pulsed With Peptides Corresponding To Tax-Specific Cytotoxic T Lymphocyte Epitopes

Expression Cloning of Genes Enabling Erythropoietin -Independent Erythropoiesis in Vitro.

Efficient Induction of Hematopoietic Progenitor/Stem Cell Differentiation by Lentiviral Gene Transduction of TAL1/SCL Into Human ES Cells.

Production of Megakaryocytes and Platelets from Common Marmoset (Callithrix jacchus) ES Cells by Constitutive Expression of tal1/scl Gene.

Secretable Human Megakaryocyte Factor V Endocytosed from Plasma in Complex with Multimerin: The Origin of Human Megakaryocyte Factor V.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only